|
Microbial Drug Resistance
Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine
To cite this article:
K. Adwan, N. Abu-Hasan, G. Adwan, N. Jarrar, B. Abu-Shanab, A. Abu-Zant.
Microbial Drug Resistance.
Spring 2005,
11(1): 75-77.
doi:10.1089/mdr.2005.11.75.
Dr. K. Adwan Department of Biological Sciences, An-Najah N. University, Nablus, Palestine. N. Abu-Hasan Department of Biological Sciences, An-Najah N. University, Nablus, Palestine. G. Adwan Department of Biological Sciences, An-Najah N. University, Nablus, Palestine. N. Jarrar Department of Biological Sciences, An-Najah N. University, Nablus, Palestine. B. Abu-Shanab Department of Biological Sciences, An-Najah N. University, Nablus, Palestine. A. Abu-Zant Department of Biological Sciences, An-Najah N. University, Nablus, Palestine. This report presents the prevalence of Palestinian isolates of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of S. aureus were identified from different patients. The prevalence of methicillin resistance among S. aureus isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among S. aureus isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).
|
|